Company intelligence / Profile preview

Stoic Bio

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Stoic Bio is a commercial-stage life science tools company providing Krakatoa, a point-of-use benchtop system and pod-based powdered media format that enables sustainable, on‑demand manufacturing of cell culture media, buffers, and balanced salt solutions for cell and gene therapy, biologics, and regenerative medicine applications.[2][3][4]

Modalities: DeviceBiologicRecombinant proteinCellular therapyGene therapy
Industry: Non-Drug Biotech

Partnerships

Center for Breakthrough Medicines (CBM) – strategic collaboration and supply agreement positioning CBM as an early adopter of Krakatoa for point‑of‑use media manufacturing[2]Nucleus Biologics – sister company and upstream custom media/formulation partner; Stoic Bio is a spinoff of Nucleus Biologics and integrates with its NB-Lux online media design platform[2][4]

Beyond the preview

Go deeper on Stoic Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stoic Bio.

Explore the full profile